# COPZ1

## Overview
COPZ1, or COPI coat complex subunit zeta 1, is a gene that encodes a protein integral to the coatomer protein complex I (COPI), which is involved in intracellular transport processes. The COPZ1 protein is categorized as a component of the vesicle trafficking machinery, playing a pivotal role in the retrograde transport of proteins from the Golgi apparatus to the endoplasmic reticulum (ER) and in maintaining Golgi structure and function (Di2020COPZ1; Anania2017Targeting). While COPZ1 is not essential for the viability of normal cells due to functional compensation by its paralog COPZ2, it is crucial for the survival of certain tumor cells, where COPZ2 is often downregulated (Anania2017Targeting; Shtutman2011Tumorspecific). This dependency makes COPZ1 a potential target for cancer therapies, as its depletion can lead to tumor cell death and enhanced immune responses (Di2020COPZ1; Anania2017Targeting). Additionally, COPZ1 is implicated in autophagy and lipid homeostasis, further underscoring its significance in cellular processes and disease contexts.

## Structure
COPZ1 (COPI coat complex subunit zeta 1) is a component of the COPI complex, which plays a crucial role in vesicle trafficking within cells. The primary structure of COPZ1 consists of a specific sequence of amino acids that determine its function and interactions. The secondary structure of COPZ1 may include alpha helices and beta sheets, which contribute to its stability and folding. The tertiary structure refers to the overall three-dimensional shape of the protein, which is essential for its interaction with other molecules and subunits within the COPI complex. The quaternary structure involves the assembly of COPZ1 with other COPI subunits, forming a functional complex necessary for its role in vesicle trafficking.

Post-translational modifications of COPZ1, such as phosphorylation or ubiquitination, can influence its function and localization within the cell. These modifications may regulate the protein's activity, stability, and interactions with other cellular components. Understanding the structural aspects of COPZ1, including its primary, secondary, tertiary, and quaternary structures, as well as its post-translational modifications, is essential for comprehending its role in cellular processes and its potential implications in various biological contexts.

## Function
COPZ1 (COPI coat complex subunit zeta 1) is a component of the coatomer protein complex I (COPI), which plays a critical role in intracellular transport processes. In healthy human cells, COPZ1 is involved in the assembly of coated vesicles on Golgi membranes and the retrograde transport of proteins from the Golgi apparatus to the endoplasmic reticulum (ER) (Anania2017Targeting). This function is essential for maintaining the structure and function of the Golgi apparatus, facilitating protein and lipid trafficking, and ensuring cellular homeostasis (Di2020COPZ1).

COPZ1 is also implicated in autophagy, a cellular process that degrades and recycles cellular components, and in maintaining lipid homeostasis (Anania2017Targeting). In normal cells, COPZ1 is not critical for cell viability, as its depletion does not significantly affect the growth of normal thyrocytes or human mammary epithelial cells, suggesting that its role can be compensated by its paralog, COPZ2 (Anania2017Targeting). This compensation allows normal cells to maintain essential cellular functions even in the absence of COPZ1, highlighting its non-essential role in non-malignant cellular contexts (Shtutman2011Tumorspecific).

## Clinical Significance
Alterations in the expression of the COPZ1 gene have significant clinical implications in various cancers. High expression of COPZ1 is associated with poor overall survival in several cancer types, including bladder cancer, breast cancer, head and neck squamous cell carcinoma, liver hepatocellular carcinoma, and lung adenocarcinoma (Hong2023A). Conversely, low expression of COPZ1 is linked to poor survival in uterine corpus endometrial carcinoma (Hong2023A). In thyroid tumors, COPZ1 depletion induces apoptotic cell death and triggers immune responses, suggesting its potential as a therapeutic target (Di2020COPZ1; Anania2017Targeting).

COPZ1 is crucial for the survival of tumor cells, particularly in cancers where its paralog, COPZ2, is downregulated, such as thyroid, breast, ovarian, and prostate cancers (Anania2017Targeting; Shtutman2011Tumorspecific). In these contexts, COPZ1 depletion can lead to cell death and enhanced anti-tumor immunity (Di2020COPZ1). The gene's role in maintaining cancer cell functions, such as proliferation and migration, is particularly evident in hepatocellular carcinoma, where its expression is significantly higher in tumor tissues compared to non-tumor tissues (Hong2023A). These findings highlight COPZ1 as a potential target for cancer therapy and a prognostic marker in various cancers.

## Interactions
COPZ1, a subunit of the coatomer protein complex I (COPI), is involved in various protein interactions crucial for cellular processes. It directly binds to nuclear receptor coactivator 4 (NCOA4), playing a significant role in regulating ferroptosis and ferritinophagy in lung adenocarcinoma (LUAD). Silencing COPZ1 leads to increased expression of NCOA4 and the autophagy marker LC3, while reducing the expression of ferritin heavy chain 1 (FTH1), indicating its involvement in promoting ferroptosis and autophagy through ferritinophagy (Wu2024COPZ1).

COPZ1 is also essential for tumor cell survival due to its interaction with its paralogous gene COPZ2. In many tumor types, COPZ2 is downregulated, making tumor cells dependent on COPZ1. This dependency is termed 'isoform addiction.' The knockdown of COPZ1 in tumor cells leads to the collapse of the Golgi apparatus, inhibition of autophagy, and induction of apoptosis, highlighting its critical role in maintaining cellular structures and processes necessary for tumor cell survival (Shtutman2011Tumorspecific).

These interactions underscore COPZ1's importance in cellular trafficking, autophagy, and tumor cell viability, making it a potential target for therapeutic strategies in cancer treatment.


## References


[1. (Anania2017Targeting) Maria Chiara Anania, Elena Cetti, Daniele Lecis, Katia Todoerti, Alessandro Gulino, Giuseppe Mauro, Tiziana Di Marco, Loredana Cleris, Sonia Pagliardini, Giacomo Manenti, Beatrice Belmonte, Claudio Tripodo, Antonino Neri, and Angela Greco. Targeting copz1 non-oncogene addiction counteracts the viability of thyroid tumor cells. Cancer Letters, 410:201–211, December 2017. URL: http://dx.doi.org/10.1016/j.canlet.2017.09.024, doi:10.1016/j.canlet.2017.09.024. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.canlet.2017.09.024)

[2. (Wu2024COPZ1) Anbang Wu, Hongmin Yang, Tengfei Xiao, Wangnin Gu, He Li, and Pan Chen. Copz1 regulates ferroptosis through ncoa4-mediated ferritinophagy in lung adenocarcinoma. Biochimica et Biophysica Acta (BBA) - General Subjects, 1868(11):130706, November 2024. URL: http://dx.doi.org/10.1016/j.bbagen.2024.130706, doi:10.1016/j.bbagen.2024.130706. This article has 0 citations.](https://doi.org/10.1016/j.bbagen.2024.130706)

[3. (Shtutman2011Tumorspecific) Michael Shtutman, Mirza Baig, Elina Levina, Gregory Hurteau, Chang-uk Lim, Eugenia Broude, Mikhail Nikiforov, Timothy T. Harkins, C. Steven Carmack, Ye Ding, Felix Wieland, Ralph Buttyan, and Igor B. Roninson. Tumor-specific silencing of copz2 gene encoding coatomer protein complex subunit ζ2 renders tumor cells dependent on its paralogous gene copz1. Proceedings of the National Academy of Sciences, 108(30):12449–12454, July 2011. URL: http://dx.doi.org/10.1073/pnas.1103842108, doi:10.1073/pnas.1103842108. This article has 45 citations.](https://doi.org/10.1073/pnas.1103842108)

[4. (Di2020COPZ1) Tiziana Di Marco, Francesca Bianchi, Lucia Sfondrini, Katia Todoerti, Italia Bongarzone, Elisa Margherita Maffioli, Gabriella Tedeschi, Mara Mazzoni, Sonia Pagliardini, Sandra Pellegrini, Antonino Neri, Maria Chiara Anania, and Angela Greco. Copz1 depletion in thyroid tumor cells triggers type i ifn response and immunogenic cell death. Cancer Letters, 476:106–119, April 2020. URL: http://dx.doi.org/10.1016/j.canlet.2020.02.011, doi:10.1016/j.canlet.2020.02.011. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.canlet.2020.02.011)

[5. (Hong2023A) Ye Hong, Zengfei Xia, Yuting Sun, Yingxia Lan, Tian Di, Jing Yang, Jian Sun, Miaozhen Qiu, Qiuyun Luo, and Dajun Yang. A comprehensive pan-cancer analysis of the regulation and prognostic effect of coat complex subunit zeta 1. Genes, 14(4):889, April 2023. URL: http://dx.doi.org/10.3390/genes14040889, doi:10.3390/genes14040889. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes14040889)